Old drug, new target: ellipticines selectively inhibit RNA polymerase I transcription. [PDF]
Andrews WJ +5 more
europepmc +1 more source
A new DNA intercalating drug: Methoxy‐9‐ellipticine [PDF]
Festy, B., Poisson, J., Paoletti, C.
openaire +2 more sources
A Multimodal Genotoxic Anticancer Drug Characterized by Pharmacogenetic Analysis in Caenorhabditis elegans. [PDF]
Ye FB +5 more
europepmc +1 more source
Modeling the Antileukemia Activity of Ellipticine-Related Compounds: QSAR and Molecular Docking Study. [PDF]
Márquez E +4 more
europepmc +1 more source
Anticancer thiosemicarbazones: chemical properties, interaction with iron metabolism, and resistance development [PDF]
Enyedy, Éva Anna +4 more
core +1 more source
ATM participates in the regulation of viability and cell cycle via ellipticine in bladder cancer. [PDF]
Tao S, Meng S, Zheng X, Xie L.
europepmc +1 more source
In vitro activity of a G-quadruplex-stabilizing small molecule that synergizes with Navitoclax to induce cytotoxicity in acute myeloid leukemia cells. [PDF]
Montoya JJ +9 more
europepmc +1 more source
Inhibition of human DNA topoisomerase IIα by two novel ellipticine derivatives. [PDF]
Vann KR +5 more
europepmc +1 more source
The Consequences of Overlapping G-Quadruplexes and i-Motifs in the Platelet-Derived Growth Factor Receptor β Core Promoter Nuclease Hypersensitive Element Can Explain the Unexpected Effects of Mutations and Provide Opportunities for Selective Targeting of Both Structures by Small Molecules To Downregulate Gene Expression. [PDF]
Brown RV +17 more
europepmc +1 more source
Synthesis and biological activity of 5-aza-ellipticine derivatives. [PDF]
Moody DL +4 more
europepmc +1 more source

